IP Library › Granted Patent US 11,406,820
Granted Patent B2
US 11,406,820 · App. 16/520,901 · Granted Aug 9, 2022

Selective modulation of intracellular effects of cells using pulsed electric fields

Inventors: Michael B. Sano (Durham, NC); Christopher B. Arena (Burlington, NC); Scott S. Verbridge (Blacksburg, VA); Rafael V. Davalos (Blacksburg, VA)
Assignee: Virginia Tech Intellectual Properties, Inc.
A61N1/327A61B18/1206A61B18/1477A61B90/37A61N1/06A61N1/08A61N1/40A61B2017/00172A61B2018/00577A61B2018/126A61B2018/143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,820
App. No.
16/520,901
Granted
Aug 9, 2022
Kind
B2
Abstract

A system and method for selectively treating aberrant cells such as cancer cells through administration of a train of electrical pulses is described. The pulse length and delay between successive pulses is optimized to produce effects on intracellular membrane potentials. Therapies based on the system and method produce two treatment zones: an ablation zone surrounding the electrodes within which aberrant cells are non-selectively killed and a selective treatment zone surrounding the ablation zone within which target cells are selectively killed through effects on intracellular membrane potentials. As a result, infiltrating tumor cells within a tumor margin can be effectively treated while sparing healthy tissue. The system and method are useful for treating various cancers in which solid tumors form and have a chance of recurrence from microscopic disease surrounding the tumor.

Claims (65)

1. A method of selectively treating cells, comprising:

activating a generator configured to generate electrical pulses with a delay between successive pulses, wherein the length of each pulse and the delay between successive pulses are optimized to produce a first treatment zone and a second treatment zone;

wherein only selected cells are affected in the second treatment zone, such that the selected cells are inhibited by way of:

slowed or arrested cell division, or

slowed or arrested migration, or

reduced transport of blood and nutrients; and

wherein the applying is performed in vitro, in vivo, or ex vivo.

2. The method of claim 1 , wherein:

some cells are killed by necrosis; or

some cells are killed by apoptosis; or

some cells are killed by necrosis and some cells are killed by apoptosis.

3. The method of claim 1 , wherein:

within the first treatment zone cells die quickly on the order of minutes; and

within the second treatment zone cells die slower on the order of hours.

4. The method of claim 1 , wherein the delay between successive pulses is greater than the length of each pulse.

5. The method of claim 1 , wherein irreversible electroporation occurs in the first treatment zone.

6. The method of claim 1 , wherein the plurality of electrical pulses comprises an electric field waveform which is:

a rectangular pulse, ramp, decaying exponential, or sine wave; and

unipolar or bipolar.

7. The method of claim 1 , wherein the pulses are bipolar square waves and the length of each pulse is between 250 nanoseconds and 50 microseconds.

8. A system for selectively treating cells, comprising:

at least one electrode; and

a voltage pulse generator operatively coupled to the electrode and configured to apply to a target region a plurality of electrical pulses with a delay between successive pulses, wherein the length of each pulse and the delay between successive pulses are optimized to produce a first treatment zone and a second treatment zone;

wherein only selected cells are affected in the second treatment zone, such that the selected cells are cancer cells which are inhibited:

by way of slowed or arrested cell division, or

by way of slowed or arrested migration, or

by way of reduced transport of blood and nutrients.

9. The system of claim 8 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that:

some cells are killed by necrosis; or

some cells are killed by apoptosis; or

some cells are killed by necrosis and some cells are killed by apoptosis.

10. The system of claim 8 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that:

within the first treatment zone cells die quickly on the order of minutes; and

within the second treatment zone cells die slower on the order of hours.

11. The system of claim 8 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that the delay between successive pulses is greater than the length of each pulse.

12. The system of claim 8 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that irreversible electroporation occurs in the first treatment zone.

13. The system of claim 8 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that the plurality of electrical pulses comprises an electric field waveform which is:

a rectangular pulse, ramp, decaying exponential, or sine wave; and

unipolar or bipolar.

14. The system of claim 8 , wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that pulses are bipolar square waves and the length of each pulse is between 250 nanoseconds and 50 microseconds.

15. An electroporation system comprising:

at least one electrode;

a voltage pulse generator operatively coupled to the at least one electrode and configured to apply a plurality of electrical pulses to a target region with a delay between successive pulses, wherein the length of each pulse and the delay between successive pulses are optimized to produce a first treatment zone and a second treatment zone;

wherein only selected cells are affected by the plurality of electrical pulses in the second treatment zone; and

wherein the voltage pulse generator is configured to apply the plurality of electrical pulses in a manner such that non-thermal ablation occurs in the first treatment zone.

16. The system of claim 15 , wherein the voltage pulse generator is configured to apply a plurality of electrical pulses such that:

some cancer cells and some non-cancer cells are killed in the first zone; or

some cancer cells are killed or inhibited, and some non-cancer cells are spared, in the second zone.

17. The system of claim 15 , wherein irreversible electroporation occurs in the first treatment zone.

18. The system of claim 15 , wherein the plurality of electrical pulses comprises an electric field waveform which is unipolar or bipolar.

19. The system of claim 18 , wherein the electric field waveform has a carrier frequency in the range of 100 kHz to 10 MHz.

20. A method of selectively treating cells, comprising:

activating a generator configured to generate electrical pulses with a delay between successive pulses, wherein the length of each pulse and the delay between successive pulses are optimized to produce a first treatment zone and a second treatment zone;

wherein only selected cells are affected in the second treatment zone; and

wherein the length of each pulse and the delay between successive pulses are based on one or more of:

physical nucleus to cytoplasm size ratio of the cancer cells;

membrane thickness, conductivity, or capacitance;

cell radius or geometric properties;

dielectric properties of cells and/or a surrounding environment;

cytoplasmic conductivity or permittivity;

relative permittivity;

a measured conductivity;

impedance; and/or

intra- or extra-cellular conductivity.

21. The method of claim 1 , wherein the selected cells are cancer cells, infiltrative cells, undesired cells, healthy cells, normal cells, and/or non-cancer cells.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
To: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
Reel/Frame 050066/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
To: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
Reel/Frame 050065/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: DAVALOS, RAFAEL V; SANO, MICHAEL B; ARENA, CHRISTOPHER B
To: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
Reel/Frame 050066/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2019
From: VERBRIDGE, SCOTT S
To: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
Reel/Frame 050065/0853 →
Continuity (3)
Continuation 15310114
Provisional Application 61992023 · May 12, 2014
Related Publication 20190351224A1 · Nov 21, 2019
Cited By (9)
US 12,201,349 US 12,214,189 US 12,232,792 US 12,390,262 US 12,390,268 US 12,484,963 US 12,485,279 US 12,697,172 US 12,708,766